Table 4 Stool pH and secretory immunoglobulin A (sIgA) stool concentrations according to group assignment in the study course: No statistically significant change between different time points within and between groups.
Baseline (n = 51) | Discharge (n = 47) | 3 Months-FU (n = 43) | ||||
|---|---|---|---|---|---|---|
Mean ± SD | Median (IQR) | Mean ± SD | Median (IQR) | Mean ± SD | Median (IQR) | |
PH | ||||||
Fasting, RA | 7.2 ± 0.8 | 7.5 (7.0–8.0) | 7.5 ± 0.5 | 7.5 (7.0–7.5) | 6.8 ± 0.5 | 7.0 (6.5–7.0) |
Fasting, FM | 7.2 ± 0.9 | 7.0 (7.0–8.0) | 7.2 ± 0.8 | 7.5 (6.5–8.0) | 6.8 ± 0.9 | 6.5 (6.5–7.5) |
MD, RA | 7.4 ± 0.8 | 7.0 (6.5–8.0) | 7.5 ± 0.5 | 7.5 (7.0–8.0) | 6.9 ± 0.7 | 7.0 (6.5–7.5) |
MD, FM | 7.4 ± 0.7 | 7.5 (6.5–8.0) | 7.3 ± 0.8 | 7.5 (6.5–8.0) | 7.2 ± 0.7 | 7.5 (6.5–7.5) |
IgA | ||||||
Fasting, RA | 1.3 ± 1.2 | 1.2 (0.4–1.4) | 1.0 ± 0.7 | 0.9 (0.6–1.1) | 1.8 ± 2.8 | 0.5 (0.4–1.4) |
Fasting, FM | 1.1 ± 1.0 | 0.7 (0.4–1.5) | 1.1 ± 0.1 | 0.7 (0.4–1.7) | 1.1 ± 0.9 | 1.0 (0.3–1.8) |
MD, RA | 1.3 ± 1.7 | 0.6 (0.2–2.1) | 0.6 ± 0.7 | 0.4 (0.3–0.6) | 0.8 ± 0.5 | 0.6 (0.5–1.0) |
MD, FM | 1.0 ± 1.2 | 0.5 (0.4–0.8) | 0.7 ± 0.9 | 0.5 (0.3–0.6) | 0.8 ± 1.1 | 0.4 (0.3–0.7) |